<DOC>
	<DOCNO>NCT02074579</DOCNO>
	<brief_summary>The aim study assess effect orally administer TU-100 ( 5 g three time daily [ TID ] ) compare placebo abdominal bloating rating female IBS patient .</brief_summary>
	<brief_title>A Safety Efficacy Study Daikenchuto ( TU-100 ) Relieve Abdominal Bloating Female Subjects With Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Meet Rome III criterion IBS ( subtype ) Female age 18 65 year , inclusive If childbearing potential , prepared use suitable form contraception throughout study 30 day last dose i.e. , hormonal contraceptive ( oral contraceptive , DepoProvera , NuvaRing , Essure ) , condom use spermicide , intrauterine device , abstinence . Females consider childbearing potential naturally postmenopausal ( menses least 1 year , &lt; 55 year age , document folliclestimulating hormone [ FSH ] level â‰¥ 35 mIU/mL ) documentation surgical sterility Have BMI 18 30 kg/m2 , inclusive Have negative pregnancy urine screen Visit 1 , childbearing potential Able provide write consent Able take oral administration test medication Have selfreported average abdominal bloating rating ( &gt; 3 daily rating precede 7 day ) equal great 4 numerical scale 0 20 . Have structural metabolic disease condition affect GI system , exclude asymptomatic gallstone uncomplicated gastroesophageal reflux disease , medical condition may cause constipation diarrhea ( e.g. , hypothyroid status , poorly control diabetes , diabetic neuropathy autonomic neuropathy ) Be take medication , opinion Principle Investigator ( PI ) , potential alter GI transit . A full list prohibit medication provide protocol . Have history presence chronic lung disease Have presence hepatic dysfunction , jaundice , abnormal serum alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) value exceed 2.5 x upper limit normal Currently pregnant lactate Have positive urine drug test screening ( subject initially test positive allow one retest ) Be know substance abuser consider alcoholic remission Have participate another clinical study past 30 day Use supplemental ginger , ginseng , Zanthoxylum fruit 2 week prior randomization throughout course study . Have history allergic reaction ginseng , ginger Zanthoxylum fruit Be clinically lactoseintolerant Have condition , opinion PI , cause subject unsuitable participate Have take antibiotic last 3 month Have gastroenteritis ( `` stomach flu '' ) last 3 month Have take probiotic last 3 month ( overthecounter [ OTC ] product supplement ; food product yogurts permit ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>Rome III criterion</keyword>
	<keyword>abdominal bloating</keyword>
	<keyword>natural</keyword>
	<keyword>herbal</keyword>
	<keyword>Kampo</keyword>
	<keyword>Adult age 18 65</keyword>
	<keyword>Female subject</keyword>
</DOC>